| |
| |
Preface | |
| |
| |
Foreword | |
| |
| |
| |
Foundations | |
| |
| |
| |
Historical Perspectives | |
| |
| |
| |
| |
Epidemiology-The United States | |
| |
| |
| |
| |
Epidemiology-A European Perspective | |
| |
| |
| |
| |
Determinants of Abuse and Dependence | |
| |
| |
| |
Genetic Factors in the Risk for Substance Use Disorders | |
| |
| |
| |
| |
Neurobiological Factors of Drug Dependence and Addiction | |
| |
| |
| |
| |
Psychological Factors (In Determinants of Abuse and Dependence) | |
| |
| |
| |
| |
Behavioral Aspects | |
| |
| |
| |
| |
Sociocultural Factors and Their Implications | |
| |
| |
| |
| |
Evaluation | |
| |
| |
| |
Clinical Assessment | |
| |
| |
| |
| |
Diagnosis and Classification: DSM-IV-TR and ICD-10 | |
| |
| |
| |
| |
Diagnostic Laboratory: Screening for Drug Abuse....123 | |
| |
| |
| |
| |
Substances of Abuse | |
| |
| |
| |
Alcohol Use Disorders | |
| |
| |
| |
| |
Opioids | |
| |
| |
| |
| |
Cocaine and Crack | |
| |
| |
| |
| |
Cannabis | |
| |
| |
| |
| |
Amphetamines and Other Stimulants | |
| |
| |
| |
| |
Sedative-Hypnotics | |
| |
| |
| |
| |
Hallucinogens | |
| |
| |
| |
| |
PCP/Designer Drugs/MDMA | |
| |
| |
| |
| |
Inhalants | |
| |
| |
| |
| |
Nicotine | |
| |
| |
| |
| |
Caffeine | |
| |
| |
| |
| |
Anabolic-Androgenic Steroids | |
| |
| |
| |
| |
Compulsive and Addictive Behaviors | |
| |
| |
| |
Eating Disorders and Substance Use Disorders | |
| |
| |
| |
| |
Pathologic Gambling | |
| |
| |
| |
| |
Sexual Addiction | |
| |
| |
| |
| |
Internet Addiction | |
| |
| |
| |
| |
Treatment Approaches | |
| |
| |
| |
Neurobiologic Treatments | |
| |
| |
| |
Methadone Maintenance | |
| |
| |
| |
| |
Buprenorphine in the Treatment of Opioid Dependence | |
| |
| |
| |
| |
Naltrexone Pharmacotherapy | |
| |
| |
| |
| |
Vaccines for Substance Abuse | |
| |
| |
| |
| |
Acupuncture | |
| |
| |
| |
| |
Alcohol Abstinence Management | |
| |
| |
| |
| |
Alternative Pharmacotherapies for Opioid Addiction | |
| |
| |
| |
| |
Sedative-Hypnotics Abstinence | |
| |
| |
| |
| |
Nicotine Dependence Management | |
| |
| |
| |
| |
Psychosocial and Other Treatments | |
| |
| |
| |
Self-Help Programs Focused on Substance Use: Active Ingredients and Outcomes | |
| |
| |
| |
| |
Alternative Support Groups | |
| |
| |
| |
| |
The Therapeutic Community | |
| |
| |
| |
| |
Network Therapy | |
| |
| |
| |
| |
Individual Psychotherapy | |
| |
| |
| |
| |
Group Therapy | |
| |
| |
| |
| |
Family/Couples Approaches to Treatment Engagement and Therapy | |
| |
| |
| |
| |
Cognitive Behavioral Therapy | |
| |
| |
| |
| |
Contingency Management in the Treatment of Substance Use Disorders: Trends in the Literature | |
| |
| |
| |
| |
Motivational Interviewing and Enhancement | |
| |
| |
| |
| |
Relapse Prevention | |
| |
| |
| |
| |
Management of Associated Medical Conditions | |
| |
| |
| |
Maternal and Neonatal Complications of Alcohol and Other Drugs | |
| |
| |
| |
| |
Medical Complications of Drug Use/Dependence | |
| |
| |
| |
| |
Psychiatric Complications of HIV-1 Infection and Drug Abuse | |
| |
| |
| |
| |
Acute and Chronic Pain | |
| |
| |
| |
| |
Substance Use Disorders in Individuals with Co-occurring Psychiatric Disorders | |
| |
| |
| |
| |
Medication Interactions | |
| |
| |
| |
| |
Models of Prevention | |
| |
| |
| |
School-Based Programs | |
| |
| |
| |
| |
Harm Reduction: New Drug Policies and Practices | |
| |
| |
| |
| |
Work Setting | |
| |
| |
| |
| |
Life Cycle | |
| |
| |
| |
Adolescent Substance Abuse | |
| |
| |
| |
| |
The Older Drug Abuser | |
| |
| |
| |
| |
Special Populations | |
| |
| |
| |
African Americans: Alcohol and Substance Abuse | |
| |
| |
| |
| |
Hispanic Americans | |
| |
| |
| |
| |
Asian Americans and Pacific Islanders | |
| |
| |
| |
| |
American Indians and Alaska Natives | |
| |
| |
| |
| |
Women and Addiction | |
| |
| |
| |
| |
Gays, Lesbians, and Bisexuals | |
| |
| |
| |
| |
Incarcerated Populations | |
| |
| |
| |
| |
Substance Use Disorders among Health Care Professionals | |
| |
| |
| |
| |
The Homeless | |
| |
| |
| |
| |
Disability, Impairment, and Addiction | |
| |
| |
| |
| |
New Immigrants and Refugees | |
| |
| |
| |
| |
Substance Use in the Armed Forces | |
| |
| |
| |
| |
Training and Education | |
| |
| |
| |
Medical Education on Addiction | |
| |
| |
| |
| |
Psychologists: Training and Education | |
| |
| |
| |
| |
Nursing Education in Addictions and Substance Abuse | |
| |
| |
| |
| |
Social Worker Education and Training in the Care of Persons with Substance Use Disorders | |
| |
| |
| |
| |
Counselor Training and Education | |
| |
| |
| |
| |
Other Mental Health Professionals | |
| |
| |
| |
| |
Policy Issues | |
| |
| |
| |
Drug Policy: A Biological Science Perspective | |
| |
| |
| |
| |
Substance Abuse Policy and Payment | |
| |
| |
| |
| |
Forensics | |
| |
| |
| |
| |
Clinical and Societal Implications of Drug Legalization | |
| |
| |
| |
| |
Future Directions | |
| |